The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Journal: Evidence-based Cardiology. 2018;11(4): 10‑15

Read: 1466 times

To cite this article:

. Evidence-based Cardiology. 2018;11(4):10‑15. (In Russ.)

References:

  1. Prince M., Bryce R., Albanese E., et al. The global prevalence of dementia: a systematic review and metaanalysis. Alzheimers Dement 2013;9:63—75. https://doi.org/10.1016/j.jalz.2012.11.007
  2. Morris J.C., Storandt M., Miller J.P., et al. Mild cognitive impairment represents early-stage Alzheimer disease. Arch Neuro 2001;58:397—405. https://doi.org/10.1001/archneur.58.3.397
  3. Whelton P.K., Carey R.M., Aronow W.S., et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/ NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension 2018;71:1269—1324. https://doi.org/10.1161/HYP.0000000000000066
  4. Kivipelto M., Helkala E.L., Hänninen T., et al. Midlife vascular risk factors and late-life mild cognitive impairment: a population-based study. Neurology 2001;56:1683—1689. https://doi.org/10.1212/WNL.56.12.1683
  5. Qiu C., Winblad B., Fratiglioni L. The age-dependent relation of blood pressure to cognitive function and dementia. Lancet Neurol 2005;4:487—499. https://doi.org/10.1016/S1474-4422(05)70141-1
  6. Schneider J.A., Arvanitakis Z., Bang W., Bennett D.A. Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology. 2007;69:2197—2204. https://doi.org/10.1212/01.wnl.0000271090.28148.24
  7. Haroutunian V., Schnaider-Beeri M., Schmeidler J., et al. Role of the neuropathology of Alzheimer disease in dementia in the oldest-old. Arch Neurol 2008;65:1211—1217. https://doi.org/10.1001/archneur.65.9.1211
  8. Savva G.M., Wharton S.B., Ince P.G., et al; Medical Research Council Cognitive Function and Ageing Study. Age, neuropathology, and dementia. N Engl J Med 2009;360:2302—2309. https://doi.org/10.1056/NEJMoa0806142
  9. Rouch L., Cestac P., Hanon O., et al. Antihypertensive drugs, prevention of cognitive decline and dementia: a systematic review of observational studies, randomized controlled trials and meta-analyses, with discussion of potential mechanisms. CNS Drugs 2015;29:113—130. https://doi.org/10.1007/s40263-015-0230-6
  10. Elias M.F., Torres R.V., Davey A. Clinical trials of blood pressure lowering and antihypertensive medication: is cognitive measurement state-of-the-art? Am J Hypertens 2018;31:631—642. https://doi.org/10.1093/ajh/hpy033
  11. Nilsson S.E., Read S., Berg S., et al. Low systolic blood pressure is associated with impaired cognitive function in the oldest old: longitudinal observations in a population-based sample 80 years and older. Aging Clin Exp Res 2007;19:41—47. https://doi.org/10.1007/BF03325209
  12. Mossello E., Pieraccioli M., Nesti N., et al. Effects of low blood pressure in cognitively impaired elderly patients treated with antihypertensive drugs. JAMA Intern Med 2015;175:578—585. https://doi.org/10.1001/jamainternmed.2014.8164
  13. Wright J.T. Jr, Williamson J.D., Whelton P.K., et al; SPRINT Research Group. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med 2015;373:2103—2116. https://doi.org/10.1056/NEJMoa1511939
  14. Williamson J.D., Supiano M.A., Applegate W.B., et al; SPRINT Research Group. Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged ≥75 years: a randomized clinical trial. JAMA 2016;315:2673—2682. https://doi.org/10.1001/jama.2016.7050
  15. 15.Nasreddine Z.S., Phillips N.A., Bédirian V., et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005;53:695—699. https://doi.org/10.1111/j.1532-5415.2005.53221
  16. 16.Wechsler D. Wechsler Adult Intelligence Scale. 4th ed. San Antonio, TX: Pearson; 2008.
  17. Wechsler D. Wechsler Memory Scale. 4th ed. San Antonio, TX: Pearson; 2009.
  18. Pfeffer R.I., Kurosaki T.T., Harrah C.H. Jr, et al. Measurement of functional activities in older adults in the community. J Gerontol 1982;37:323—329. https://doi.org/10.1093/geronj/37.3.323
  19. Gaussoin S.A., Espeland M.A., Absher J., et al. Ascertaining dementia-related outcomes for deceased or proxy-dependent participants: an overview of the Women’s Health Initiative Memory Study supplemental case ascertainment protocol. Int J Geriatr Psychiatry 2012;27:205—214. https://doi.org/10.1002/gps.2714
  20. Welsh K., Breitner J.C.S, Magruder-Habib K. Detection of dementia in the elderly using telephone screening of cognitive status. Neuropsychiatry Neuropsychol Behav Neurol 1993;6:103—110.
  21. Kawas C., Segal J., Stewart W.F., et al. A validation study of the Dementia Questionnaire. Arch Neurol 1994;51:901—906. https://doi.org/10.1001/archneur.1994.00540210073015
  22. 22.Berlowitz D.R., Foy C.G., Kazis L.E., et al.; SPRINT Research Group. Effect of intensive blood-pressure treatment on patient-reported outcomes. N Engl J Med 2017;377:733—744. https://doi.org/10.1056/NEJMoa1611179
  23. 23.McKhann G.M., Knopman D.S., Chertkow H., et al. The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging—Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 2011;7:263—269. https://doi.org/10.1016/j.jalz.2011.03.005
  24. 24.Albert M.S., DeKosky S.T., Dickson D., et al. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging—Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 2011;7:270—279. https://doi.org/10.1016/j.jalz.2011.03.008
  25. Prince M., Wimo A., Guerchet M., et al. World Alzheimer Report 2015: The Global Impact of Dementia: An Analysis of Prevalence, Incidence, Cost and Trends. London, England: Alzheimer’s Disease International; 2015.
  26. Yaffe K. Prevention of Cognitive Impairment With Intensive Systolic Blood Pressure Control. JAMA 2019 Jan 28. https://doi.org/10.1001/jama.2019.0008. [Epub ahead of print]
  27. Gottesman R.F., Schneider A.L., Zhou Y., et al. Association between midlife vascular risk factors and estimated brain amyloid deposition. JAMA 2017;317:1443—1450. https://doi.org/10.1001/jama.2017.3090.
  28. Gottesman R.F., Albert M.S., Alonso A., et al. Associations between midlife vascular risk factors and 25-year incident dementia in the Atherosclerosis Risk in Communities (ARIC) cohort. JAMA Neurol 2017;74:1246—1254. https://doi.org/10.1001/jamaneurol.2017.1658.
  29. Boyle P.A., Yu L., Wilson R.S., et al. Person-specific contribution of neuropathologies to cognitive loss in old age. Ann Neurol 2018;83:74—83. https://doi.org/10.1002/ana.25123
  30. Iadecola C., Yaffe K., Biller J., et al.; American Heart Association Council on Hypertension, Council on Clinical Cardiology, Council on Cardiovascular Disease in the Young, Council on Cardiovascular and Stroke Nursing, Council on Quality of Care and Outcomes Research, and Stroke Council. Impact of hypertension on cognitive function: a scientific statement from the American Heart Association. Hypertension 2016;68:e67—e94. https://doi.org/10.1161/HYP.0000000000000053
  31. Barnes D.E., Yaffe K. The projected effect of risk factor reduction on Alzheimer’s disease prevalence. Lancet Neurol 2011;10:819—828. https://doi.org/10.1016/S1474-4422(11)70072-2
  32. Hajjar I., Rosenberger K.J., Kulshreshtha A., et al. Association of JNC-8 and SPRINT systolic blood pressure levels with cognitive function and related racial disparity. JAMA Neurol 2017;74:1199—1205. https://doi.org/10.1001/jamaneurol.2017.1863
  33. Williamson J.D., Supiano M.A., Applegate W.B., et al; SPRINT Research Group. Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged ≥75 years: a randomized clinical trial. JAMA 2016;315:2673—2682. https://doi.org/10.1001/jama.2016.7050
  34. Corrada M.M., Hayden K.M., Paganini-Hill A., et al. Age of onset of hypertension and risk of dementia in the oldest-old: the 90+ Study. Alzheimers Dement 2017;13:103—110. https://doi.org/10.1016/j.jalz.2016.09.007
  35. Yaffe K., Vittinghoff E., Pletcher M.J., et al. Early adult to midlife cardiovascular risk factors and cognitive function. Circulation 2014;129:1560—1567. https://doi.org/10.1161/CIRCULATIONAHA.113.004798

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.